Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07835581
PHASE3
Phase 3 Randomized Study of Tegoprubart Efficacy and Safety Compared With Tacrolimus in Kidney Transplantation
Sponsor: Eledon Pharmaceuticals
View on ClinicalTrials.gov
Summary
This study will evaluate the efficacy and safety of tegoprubart compared with tacrolimus in adult participants undergoing first kidney transplantation.
Official title: A Multicenter, Phase 3 Randomized, Active-Controlled, Open-Label Study to Evaluate the Efficacy and Safety of Tegoprubart Compared With Tacrolimus in Adult Participants Undergoing De Novo Kidney Transplantation
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
620
Start Date
2026-10
Completion Date
2033-03
Last Updated
2026-09-23
Healthy Volunteers
No
Conditions
Interventions
DRUG
Tegoprubart
Tegoprubart administered via IV infusion
DRUG
Tacrolimus
Tacrolimus administered orally